2,500
Participants
Start Date
November 28, 2017
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling
Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling. This will enable patient enrolment into a currently available PRIMUS study
RECRUITING
Aberdeen Royal Infirmary, Aberdeen
RECRUITING
Northern Ireland Cancer Centre, Belfast
RECRUITING
Queen Elizabeth Hospital, Birmingham
RECRUITING
Royal Bournemouth Hospital, Bournemouth
RECRUITING
Bristol Oncology Centre, Bristol
RECRUITING
Addenbrooke's Hospital, Cambridge
RECRUITING
Castle Hill Hospital, Cottingham
RECRUITING
Ninewells Hospital, Dundee
RECRUITING
Western General, Edinburgh
RECRUITING
Glasgow Royal Infirmary, Glasgow
RECRUITING
Huddersfield Royal Infirmary, Huddersfield
RECRUITING
Raigmore Hospital, Inverness
RECRUITING
St James's Hospital, Leeds
RECRUITING
Royal Liverpool Hospital, Liverpool
RECRUITING
Guy's Hospital, London
RECRUITING
Imperial College Healthcare Trust, London
RECRUITING
King's College Hospital, London
RECRUITING
Royal Free London Hospital, London
RECRUITING
Royal Marsden Hospital, London
RECRUITING
St Bart's Hospital, London
RECRUITING
St George's Hospital, London
RECRUITING
University College London Hospital, London
RECRUITING
Manchester Royal Infirmary, Manchester
RECRUITING
The Christie, Manchester, Manchester
RECRUITING
Milton Keynes Hospital, Milton Keynes
RECRUITING
Freeman Hospital, Newcastle
RECRUITING
Nottingham Hospitals NHS Trust, Nottingham
RECRUITING
Churchill Hospital, Oxford
RECRUITING
Pool Hospital, Poole
RECRUITING
Weston Park, Sheffield
RECRUITING
University Hospital Southampton, Southampton
RECRUITING
Morriston Hospital, Swansea
RECRUITING
Royal Albert Edward Infirmary, Wigan
Collaborators (1)
Cancer Research UK
OTHER
NHS Greater Glasgow and Clyde
OTHER
Judith Dixon-Hughes
OTHER